# US 2025/0205294 A1 · Composition for ameliorating obesity or lipid metabolism comprising asimina triloba extract

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0205294 A1
- Document ID: US20250205294A1
- Status: Published application
- Kind: A1
- Application number: 18/852,038
- Filed: 2022-12-20
- Published: 2025-06-26
- Earliest claimed: 2022-03-31
- Assignees: Korea Food Research Institute
- Applicants: Korea Food Research Institute
- Inventors: Sang Yoon CHOI; Chang Jun LEE; Jin Young HUR; Guijae YOO; Hyun Hee LEE; Yoon Sook KIM; In Wook CHOI
- Web page: https://patentgrep.com/patent/US20250205294A1

## CPC

- A61K 36/185: Magnoliopsida (dicotyledons)
- A23L 33/105: Plant extracts, their artificial duplicates or their derivatives
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 9/12: Antihypertensives
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a composition for ameliorating, treating or preventing obesity or lipid metabolism, or metabolic diseases, comprising an Asimina triloba extract. The Asimina triloba extract according to the present invention has the effect of ameliorating, preventing or treating obesity, lipid metabolism, or lipid-related metabolic diseases, and thus, a pharmaceutical composition, a food composition, a health functional food, a quasi-drug composition, and a feed composition, while comprise the Asimina triloba extract as an active ingredient, can be effectively used for the prevention, treatment or amelioration of obesity.

## Claims

### Claim 1

A food composition for ameliorating or preventing obesity, lipid metabolism, or metabolic diseases, comprising an Asimina triloba extract as an active ingredient.

### Claim 2 (depends on 1)

The food composition of claim 1, wherein the extract is one or more selected from the group consisting of seeds, fruits, roots, stems, and leaves of Asimina triloba.

### Claim 3 (depends on 1)

The food composition of claim 1, wherein the extract is a crude extract obtained by extraction with a solvent selected from the group consisting of water, an alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof.

### Claim 4 (depends on 1)

The food composition of claim 1, wherein the extract is an extract obtained by extraction with a solvent selected from the group consisting of glycerin, butylene glycol, propylene glycol, methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, dichloromethane, or a mixed solvent thereof.

### Claim 5 (depends on 1)

The food composition of claim 1, wherein the metabolic disease is one or more selected from the group consisting of diabetes, diabetic complications, stroke, hyperlipidemia, fatty liver, arteriosclerosis, hypertension, cardiovascular diseases, or metabolic syndrome in which the above diseases occur simultaneously.

### Claim 6 (depends on 1)

The food composition of claim 1, wherein the extract inhibits differentiation of preadipocyte cells and inhibits expression of transcription factors involved in adipogenesis and preadipocyte cell differentiation.

### Claim 7

A pharmaceutical composition for preventing or treating obesity or metabolic diseases, comprising an Asimina triloba extract as an active ingredient.

### Claim 8 (depends on 7)

The pharmaceutical composition of claim 7, wherein the extract is one or more selected from the group consisting of seeds, fruits, roots, stems, and leaves of Asimina triloba.

### Claim 9 (depends on 7)

The pharmaceutical composition of claim 7, wherein the extract is a crude extract obtained by extraction with a solvent selected from the group consisting of water, an alcohol having 1 to 4 carbon atoms, or a mixed solvent thereof.

### Claim 10 (depends on 7)

The pharmaceutical composition of claim 7, wherein the extract is an extract obtained by extraction with a solvent selected from the group consisting of glycerin, butylene glycol, propylene glycol, methyl acetate, ethyl acetate, acetone, benzene, hexane, diethyl ether, dichloromethane, or a mixed solvent thereof.

### Claim 11 (depends on 7)

The pharmaceutical composition of claim 7, wherein the metabolic disease is one or more selected from the group consisting of diabetes, diabetic complications, stroke, hyperlipidemia, fatty liver, arteriosclerosis, hypertension, cardiovascular diseases, or metabolic syndrome in which the above diseases occur simultaneously.

### Claim 12 (depends on 7)

The pharmaceutical composition of claim 7, wherein the extract inhibits differentiation of preadipocyte cells and inhibits expression of transcription factors involved in adipogenesis and preadipocyte cell differentiation.

### Claim at position 13

13-22. (canceled)

### Claim 23

A method for preventing or treating obesity or lipid metabolism, or metabolic disease, comprising administering to a subject a composition comprising an Asimina triloba extract as an active ingredient.

### Claim at position 15

24-25. (canceled)
